Linkout box

Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !> A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.drudis.2020.02.011

http://scihub22266oqcxt.onion/10.1016/j.drudis.2020.02.011

32198066!7102657!32198066
    free
    free
    free

Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=32198066&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215

      Drug+Discov+Today 2020 ; 25 (5): 810-812
Nephropedia Template TP
{{tp|p=32198066|t=2020. Advance of promising targets and agents against COVID-19 in China |pdf=|usr=}}{{32198066}}
gab.com Text
Advance of promising targets and agents against COVID-19 in China JO: Drug Discov Today http://www.kidney.de/pget.php?&tw=1&pmid=32198066 #FOAvip ?
Twit Text FOAVip
Advance of promising targets and agents against COVID-19 in China ????Drug Discov Today http://www.kidney.de/pget.php?&tw=1&pmid=32198066 #FOAvip
Twit Text #
Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32198066 #FOAvip
English Wikipedia
<ref>{{Cite pmid|32198066}}</ref>

Advance of promising targets and agents against COVID-19 in China #MMPMID32198066
Duan Y; Zhu HL; Zhou C
Drug Discov Today 2020[May]; 25 (5): 810-812 PMID32198066show ga
?
|Adenine/analogs & derivatives/therapeutic use[MESH]
|Adenosine Monophosphate/analogs & derivatives/therapeutic use[MESH]
|Alanine/analogs & derivatives/therapeutic use[MESH]
|Amides/therapeutic use[MESH]
|Antimalarials/therapeutic use[MESH]
|Antiviral Agents/*therapeutic use[MESH]
|Betacoronavirus/*metabolism[MESH]
|COVID-19[MESH]
|COVID-19 Drug Treatment[MESH]
|China[MESH]
|Chloroquine/therapeutic use[MESH]
|Clinical Trials as Topic[MESH]
|Cobicistat/therapeutic use[MESH]
|Coronavirus 3C Proteases[MESH]
|Coronavirus Infections/*drug therapy[MESH]
|Cysteine Endopeptidases/metabolism[MESH]
|Dibenzothiepins[MESH]
|Drug Combinations[MESH]
|Drug Discovery[MESH]
|Drug Therapy, Combination[MESH]
|Emtricitabine/therapeutic use[MESH]
|Humans[MESH]
|Hydroxychloroquine/therapeutic use[MESH]
|Indoles/therapeutic use[MESH]
|Lopinavir/therapeutic use[MESH]
|Medicine, Chinese Traditional[MESH]
|Morpholines[MESH]
|Oseltamivir/therapeutic use[MESH]
|Oxazines/therapeutic use[MESH]
|Pandemics[MESH]
|Pneumonia, Viral/*drug therapy[MESH]
|Pyrazines/therapeutic use[MESH]
|Pyridines/therapeutic use[MESH]
|Pyridones[MESH]
|RNA-Dependent RNA Polymerase/metabolism[MESH]
|Ritonavir/therapeutic use[MESH]
|SARS-CoV-2[MESH]
|Spike Glycoprotein, Coronavirus/metabolism[MESH]
|Tenofovir/therapeutic use[MESH]
|Thiepins/therapeutic use[MESH]
|Triazines/therapeutic use[MESH]Advance of promising targets and agents against COVID-19 in China (epmc).pdf

DeepDyve
Pubget Overpricing

Linkout box